BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 10623654)

  • 21. Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma.
    Takahashi K; Ofuji K; Hiramatsu K; Nosaka T; Naito T; Matsuda H; Endo K; Higuchi M; Ohtani M; Nemoto T; Nakamoto Y
    Cancer Med; 2021 Apr; 10(7):2300-2309. PubMed ID: 33675149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls.
    Hofman VJ; Ilie MI; Bonnetaud C; Selva E; Long E; Molina T; Vignaud JM; Fléjou JF; Lantuejoul S; Piaton E; Butori C; Mourad N; Poudenx M; Bahadoran P; Sibon S; Guevara N; Santini J; Vénissac N; Mouroux J; Vielh P; Hofman PM
    Am J Clin Pathol; 2011 Jan; 135(1):146-56. PubMed ID: 21173137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis.
    De Giorgi V; Pinzani P; Salvianti F; Grazzini M; Orlando C; Lotti T; Pazzagli M; Massi D
    Arch Dermatol; 2010 Oct; 146(10):1120-4. PubMed ID: 20956643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
    Nam SJ; Yeo HY; Chang HJ; Kim BH; Hong EK; Park JW
    Cancer Res Treat; 2016 Oct; 48(4):1229-1242. PubMed ID: 27034142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical value and feasibility of ISET in detecting circulating tumor cells in early breast cancer.
    Zeng H; Veeramootoo JS; Ma G; Jiang Y; Wang J; Xia T; Liu X
    Transl Cancer Res; 2020 Jul; 9(7):4297-4305. PubMed ID: 35117796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating biomarkers in hepatocellular carcinoma.
    Morris KL; Tugwood JD; Khoja L; Lancashire M; Sloane R; Burt D; Shenjere P; Zhou C; Hodgson C; Ohtomo T; Katoh A; Ishiguro T; Valle JW; Dive C
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):323-32. PubMed ID: 24923562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
    Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
    Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions.
    Wu S; Liu Z; Liu S; Lin L; Yang W; Xu J
    Clin Chem Lab Med; 2014 Feb; 52(2):243-51. PubMed ID: 24021598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biofunctionalized magnetic nanospheres-based cell sorting strategy for efficient isolation, detection and subtype analyses of heterogeneous circulating hepatocellular carcinoma cells.
    Chen L; Wu LL; Zhang ZL; Hu J; Tang M; Qi CB; Li N; Pang DW
    Biosens Bioelectron; 2016 Nov; 85():633-640. PubMed ID: 27240010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization.
    Cohen EN; Jayachandran G; Hardy MR; Venkata Subramanian AM; Meng X; Reuben JM
    PLoS One; 2020; 15(10):e0241123. PubMed ID: 33095819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer.
    Pailler E; Auger N; Lindsay CR; Vielh P; Islas-Morris-Hernandez A; Borget I; Ngo-Camus M; Planchard D; Soria JC; Besse B; Farace F
    Ann Oncol; 2015 Jul; 26(7):1408-15. PubMed ID: 25846554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation.
    Waguri N; Suda T; Nomoto M; Kawai H; Mita Y; Kuroiwa T; Igarashi M; Kobayashi M; Fukuhara Y; Aoyagi Y
    Clin Cancer Res; 2003 Aug; 9(8):3004-11. PubMed ID: 12912949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
    Matsumura M; Niwa Y; Kato N; Komatsu Y; Shiina S; Kawabe T; Kawase T; Toyoshima H; Ihori M; Shiratori Y
    Hepatology; 1994 Dec; 20(6):1418-25. PubMed ID: 7527002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells.
    Lim LS; Hu M; Huang MC; Cheong WC; Gan AT; Looi XL; Leong SM; Koay ES; Li MH
    Lab Chip; 2012 Nov; 12(21):4388-96. PubMed ID: 22930096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.
    Bozzetti C; Quaini F; Squadrilli A; Tiseo M; Frati C; Lagrasta C; Azzoni C; Bottarelli L; Galetti M; Alama A; Belletti S; Gatti R; Passaro A; Gradilone A; Cavazzoni A; Alfieri R; Petronini PG; Bonelli M; Falco A; Carubbi C; Pedrazzi G; Nizzoli R; Naldi N; Pinto C; Ardizzoni A
    PLoS One; 2015; 10(11):e0142891. PubMed ID: 26571236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.
    Li YM; Xu SC; Li J; Han KQ; Pi HF; Zheng L; Zuo GH; Huang XB; Li HY; Zhao HZ; Yu ZP; Zhou Z; Liang P
    Cell Death Dis; 2013 Oct; 4(10):e831. PubMed ID: 24091674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumorous cells in patients with hepatocellular carcinoma. Clinical impact and future directions.
    Paterlini-Bréchot P; Vona G; Bréchot C
    Semin Cancer Biol; 2000 Jun; 10(3):241-9. PubMed ID: 10936072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microfluidic-Based Enrichment and Retrieval of Circulating Tumor Cells for RT-PCR Analysis.
    Gogoi P; Sepehri S; Chow W; Handique K; Wang Y
    Methods Mol Biol; 2017; 1634():55-64. PubMed ID: 28819840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs).
    Kallergi G; Politaki E; Alkahtani S; Stournaras C; Georgoulias V
    Cell Physiol Biochem; 2016; 40(3-4):411-419. PubMed ID: 27889762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection.
    Sabile A; Louha M; Bonte E; Poussin K; Vona G; Mejean A; Chretien Y; Bougas L; Lacour B; Capron F; Roseto A; Bréchot C; Paterlini-Bréchot P
    Am J Clin Pathol; 1999 Aug; 112(2):171-8. PubMed ID: 10439796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.